Parkinson’s Treatment Quality Improvement Initiative- NPF Enrolls 5000

The University of Florida Center for Movement Disorders & Neurorestoration is a proud participant in this program. It is exciting to see NPF reach this milestone.

NPF’s Landmark Quality Improvement Initiative
Enrolls 5,000 Parkinson’s Patients

New Findings Presented at the American Academy of Neurology’s 64th Annual Meeting in New Orleans

CoE_4C_Seal
The National Parkinson Foundation (NPF) announced today that there are now 5,000 people with Parkinson’s enrolled in its Quality Improvement Initiative (QII), the largest-ever study of clinical care and outcomes in Parkinson’s. The QII builds on a model proven to dramatically increase longevity in cardiovascular surgery and cystic fibrosis. The goal of NPF’s QII is to improve care of people with Parkinson’s by identifying and implementing best practices across NPF centers and beyond. At present, 20 NPF Centers of Excellence participate in the study.

“By measuring treatments and their outcomes of this comprehensive cohort, we can improve care outcomes for all patients with Parkinson’s,” said Eugene Nelson, DSc, MPH, Director, Population Health Measurement Program, Dartmouth Institute for Health Policy and Clinical Practice. “Thus far, QII has shown us that care practices vary at expert centers and that these differences affect people’s quality of life. Using the data collected, we plan to create evidence-based recommendations for Parkinson’s care that we hope will provide greater relief for patients and their families.”

NPF’s QII is being used across NPF Centers of Excellence to inform this guideline development. Analysis of the QII data has already identified important findings which could influence the quality of care across NPF Centers and beyond. Two studies will be presented at the American Academy of Neurology’s (AAN) 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.

The QII builds on a model proven to dramatically increase longevity in cardiovascular surgery and cystic fibrosis. The goal of NPF’s QII is to improve care of people with Parkinson’s by identifying and implementing best practices across NPF centers and beyond. At present, 20 NPF Centers of Excellence participate in the study.

“By measuring treatments and their outcomes of this comprehensive cohort, we can improve care outcomes for all patients with Parkinson’s,” said Eugene Nelson, DSc, MPH, Director, Population Health Measurement Program, Dartmouth Institute for Health Policy and Clinical Practice. “Thus far, QII has shown us that care practices vary at expert centers and that these differences affect people’s quality of life. Using the data collected, we plan to create evidence-based recommendations for Parkinson’s care that we hope will provide greater relief for patients and their families.”

NPF’s QII is being used across NPF Centers of Excellence to inform this guideline development. Analysis of the QII data has already identified important findings which could influence the quality of care across NPF Centers and beyond. Two studies will be presented at the American Academy of Neurology’s (AAN) 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.